Literature DB >> 11774406

Carcinoma of the skin of the head and neck with perineural invasion.

William M Mendenhall1, Robert J Amdur, Lorna Sohn Williams, Anthony A Mancuso, Scott P Stringer, Nancy Price Mendenhall.   

Abstract

BACKGROUND: Perineural invasion is observed in a small subset of patients with carcinomas of the skin of the head and neck.
METHODS: Review of the patient literature highlighting the University of Florida experience.
RESULTS: Patients with early perineural invasion are asymptomatic, and the phenomenon is discovered only on pathologic examination of the excised lesion. These patients are defined as having "incidental" perineural invasion, and treatment with surgery followed by postoperative irradiation results in a cure rate of approximately 80%. Undiagnosed, the perineural carcinoma slowly progresses and eventually results in symptoms, usually facial weakness or numbness. The disease eventually extends to the skull base and becomes incompletely resectable. Symptomatic patients are defined as having "clinical" perineural invasion, and aggressive treatment results in a cure rate of approximately 45%.
CONCLUSIONS: Perineural invasion is an uncommon spread pattern observed in patients with skin cancer and is associated with a relatively poor prognosis. The likelihood of cure is inversely related to the proximal extent of the cancer and is lower for symptomatic compared with asymptomatic patients. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11774406     DOI: 10.1002/hed.10025

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  20 in total

1.  Histological characteristics of intra-temporal facial nerve paralysis in temporal bone malignancies.

Authors:  Omer J Ungar; Joseph B Nadol; William C Faquin; John P Carey; Ophir Handzel; Felipe Santos
Journal:  Laryngoscope       Date:  2019-08-01       Impact factor: 3.325

Review 2.  Perineural growth in head and neck squamous cell carcinoma: a review.

Authors:  Joseph Roh; Thomas Muelleman; Ossama Tawfik; Sufi M Thomas
Journal:  Oral Oncol       Date:  2014-10-25       Impact factor: 5.337

3.  The Natural History and Treatment Outcomes of Perineural Spread of Malignancy within the Head and Neck.

Authors:  Timothy A Warren; Christina M Nagle; James Bowman; Benedict J Panizza
Journal:  J Neurol Surg B Skull Base       Date:  2016-03-10

4.  Elective management of cervical and parotid lymph nodes in stage N0 cutaneous squamous cell carcinoma of the head and neck: a decision analysis.

Authors:  Wai Keat Wong; Randall P Morton
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-12-14       Impact factor: 2.503

Review 5.  [Squamous epithelial carcinomas of the face with neurotropic growth].

Authors:  S Ständer; H Ständer; H Kutzner; T A Luger; D Metze
Journal:  Hautarzt       Date:  2003-06-25       Impact factor: 0.751

6.  Surgical Management of Perineural Spread of Head and Neck Cancers.

Authors:  C Arturo Solares; Eric Mason; Benedict J Panizza
Journal:  J Neurol Surg B Skull Base       Date:  2016-03-18

7.  Perineural invasion through the maxillary division of the right trigeminal nerve in a rare case of nasolabial malignant peripheral nerve sheath tumor.

Authors:  C Sempere-Ortega; J Martinez-San-Millan
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-26       Impact factor: 3.825

8.  Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review.

Authors:  Rodrigo Luna; Laura M Fayad; Fausto J Rodriguez; Shivani Ahlawat
Journal:  Skeletal Radiol       Date:  2020-07-23       Impact factor: 2.199

9.  Imaging of skull base tumours.

Authors:  Stefanie Catherine Thust; Tarek Yousry
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-02

10.  Diagnostic Challenge: Sequential Unilateral Cranial Neuropathies Due to Perineural Spread of Carcinoma.

Authors:  Heather E Moss; Peter W MacIntosh; Konstantin V Slavin; John M Collins
Journal:  Neuroophthalmology       Date:  2017-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.